You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Enzyme inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)

Recruiting
  • Anemia in Dialysis-dependent CKD Patients
  • Alexandria, Egypt
    Alexandria University
Oct 29, 2023

Tranexamic Acid for Angiotensin-converting Enzyme

Completed
  • Angioedema
    • Dallas, Texas
      Methodist Dallas Medical Center
    Oct 17, 2023

    Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor Trial in Saint Louis (High ACE Activity Fresh Frozen Plasma, Normal

    Recruiting
    • Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor
    • High ACE Activity Fresh Frozen Plasma
    • Normal Saline
    • Saint Louis, Missouri
      Barnes-Jewish Hospital
    Oct 24, 2022

    Precision Treatment With Angiotensin Converting Enzyme Inhibitor

    Recruiting
    • Hypertension
    • +2 more
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Sep 7, 2022

      Chronic Kidney Diseases Trial (Placebo, Co-Enzyme Q10)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Placebo
      • Co-Enzyme Q10
      • (no location specified)
      Jul 4, 2023

      Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Placebo
      • Vitamin K 2
      • (no location specified)
      Jul 4, 2023

      Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia Trial (VLX-1005, Placebo)

      Not yet recruiting
      • Thrombocytopenia, Immune
      • Heparin Induced Thrombocytopenia
      • (no location specified)
      Mar 24, 2023

      Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)

      Not yet recruiting
      • Diabetic Nephropathy Type 2
      • Empagliflozin 25 MG
      • Enalapril Maleate 20 mg
      • (no location specified)
      May 9, 2022

      Bradykinin-degradating Enzymes Activities in

      Recruiting
      • Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor
      • Assay of Bradykinin-degradating enzymes.
      • Grenoble, France
        Chu Grenoble Alpes
      Jan 14, 2022

      Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

      Terminated
      Has Results
      • Locally Advanced Malignant Solid Neoplasm
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 22, 2022

      C3 Glomerulopathy, Membranoproliferative Glomerulonephritis, Complement Abnormality Trial in Sweden (Aliskiren, Enalapril)

      Recruiting
      • C3 Glomerulopathy
      • +4 more
      • Gothenburg, Sweden
      • +3 more
      Jan 4, 2022

      Hypertension, COVID-19 Trial in Kiev (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers, Direct renin

      Completed
      Has Results
      • Hypertension
      • COVID-19
      • Angiotensin converting enzyme inhibitor
      • +2 more
      • Kiev, Please Select, Ukraine
        Medical Practice Prof D.Ivanov
      Feb 16, 2022

      Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +5 more
      • Duarte, California
        City of Hope Medical Center
      Jan 4, 2023

      Oxidative Stress Trial in Guadalajara (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers)

      Completed
      • Oxidative Stress
      • Angiotensin converting enzyme inhibitor
      • Angiotensin Receptor Blockers
      • Guadalajara, Jalisco, Mexico
        Enrique Rojas Campos
      Feb 8, 2022

      Chronic Kidney Disease, Blood Pressure, Angiotensin-converting Enzyme Inhibitor Trial in San Francisco (Continuation of ACEi

      Active, not recruiting
      • Chronic Kidney Disease
      • +3 more
      • Continuation of ACEi and/or ARBs
      • San Francisco, California
        University of California, San Francisco
      Oct 4, 2021

      Hypertension Trial in London (Preoperative ACEi/ARB management)

      Completed
      • Hypertension
      • Preoperative ACEi/ARB management
      • London, Ontario, Canada
        London Health Sciences Centre
      Oct 21, 2021

      Diabetic Kidney Disease Trial in Australia (SER150, Placebo)

      Recruiting
      • Diabetic Kidney Disease
      • Liverpool, New South Wales, Australia
      • +6 more
      May 17, 2022

      Idiopathic Membranous Nephropathy Trial in Paris (symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II,

      Completed
      • Idiopathic Membranous Nephropathy
      • symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
      • experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
      • Paris, France
        Department of Nephrology , Tenon hospital - APHP
      Oct 18, 2021

      Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia Trial in United States

      Active, not recruiting
      • Recurrent Acute Myeloid Leukemia
      • +3 more
      • Tampa, Florida
      • +5 more
      Nov 18, 2022

      Recurrent Lymphoma, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan,

      Active, not recruiting
      Has Results
      • Recurrent Lymphoma
      • +5 more
      • Birmingham, Alabama
      • +19 more
      Oct 20, 2022

      Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

      Terminated
      Has Results
      • Clear Cell Renal Cell Carcinoma
      • +3 more
      • Buffalo, New York
      • +1 more
      Aug 11, 2022

      Acute Myelogenous Leukemia Trial in Rochester, Milwaukee (Azacitidine, Venetoclax, Pevonedistat)

      Active, not recruiting
      • Acute Myelogenous Leukemia
      • Rochester, Minnesota
      • +1 more
      Sep 21, 2021

      Myocardial Infarction With Non-obstructive Coronary Arteries Trial in Worldwide (Beta blocker, ACEI, ARB)

      Recruiting
      • Myocardial Infarction With Non-obstructive Coronary Arteries
      • Beta blocker
      • +2 more
      • Adelaide, Sout Australi, Australia
      • +19 more
      Sep 6, 2021

      Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,

      Completed
      • Adenocarcinoma of the Pancreas
      • +3 more
      • dovitinib lactate
      • +5 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jul 20, 2022

      Hemodialysis Trial in Cairo (Ramipril, )

      Completed
      • Hemodialysis
      • Cairo, Egypt
        Ain Shams University Hospital
      Oct 10, 2020